Last updated: 30 June 2020 at 8:26pm EST

Human Genetic Therapies, In... Net Worth




The estimated Net Worth of Human Genetic Therapies, In... is at least $158 Million dollars as of 3 June 2020. Human In owns over 40,086 units of Telesis Bio Inc stock worth over $11,602,486 and over the last 4 years Human sold TBIO stock worth over $146,169,238.

Human In TBIO stock SEC Form 4 insiders trading

Human has made over 3 trades of the Telesis Bio Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently Human sold 6,824,992 units of TBIO stock worth $141,140,835 on 30 June 2020.

The largest trade Human's ever made was selling 6,824,992 units of Telesis Bio Inc stock on 30 June 2020 worth over $141,140,835. On average, Human trades about 2,359,648 units every 10 days since 2020. As of 3 June 2020 Human still owns at least 6,824,992 units of Telesis Bio Inc stock.

You can see the complete history of Human In stock trades at the bottom of the page.



What's Human In's mailing address?

Human's mailing address filed with the SEC is 300 SHIRE WAY1-1, NIHONBASHI-HONCHO 2-CHOME, , LEXINGTONCHUO-KU, TOKYO, MAM0, 02421103-8668.

Insiders trading at Telesis Bio Inc

Over the last 6 years, insiders at Telesis Bio Inc have traded over $269,224,467 worth of Telesis Bio Inc stock and bought 73,047,057 units worth $2,753,701,666 . The most active insiders traders include Sanofi, Plc Gsk, and Human Genetic Therapies, In.... On average, Telesis Bio Inc executives and independent directors trade stock every 88 days with the average trade being worth of $7,100,681. The most recent stock trade was executed by Todd Robert Nelson on 4 May 2023, trading 2,575 units of TBIO stock currently worth $7,287.



What does Telesis Bio Inc do?

sgi-dna, a wholly owned subsidiary of synthetic genomics inc., provides genomic solutions to advance scientific discovery. sgi-dna’s ever expanding suite of products, services, reagents, bioinformatics tools and instrumentation enables scientists to discover, design and build novel solutions for basic research, as well as for biomedical and industrial applications. sgi-dna’s genomic services include whole genome sequencing, dna synthesis, library design, bioinformatics, cell engineering, and plasmid dna cloning and purification. sgi-dna’s reagents include a complete suite of gibson assembly® and site directed mutagenesis kits as well as optimized cell lines such as vmax™ a novel, fast growing host system for molecular biology. to further enable synthetic biology workflows, sgi-dna offers the bioxp™ 3200 system. this fully automated genomics workstation allows the creation of double stranded dna fragments, automated cloning, as well as next generation sequencing dna library preparation.



What does Telesis Bio Inc's logo look like?

Telesis Bio Inc logo

Complete history of Human In stock trades at Telesis Bio Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
30 Jun 2020 Human Genetic Therapies, In...
Sale 6,824,992 $20.68 $141,140,835
30 Jun 2020
0
3 Jun 2020 Human Genetic Therapies, In...
Sale 40,086 $19.75 $791,699
3 Jun 2020
6,824,992
1 Jun 2020 Human Genetic Therapies, In...
Sale 213,867 $19.81 $4,236,705
1 Jun 2020
6,865,078


Telesis Bio Inc executives and stock owners

Telesis Bio Inc executives and other stock owners filed with the SEC include: